FLGT
Fulgent Genetics Inc
21.30$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.7% | -8.5% | +10.1% | +1.0% | +6.2% | -3.6% | +11.4% | +2.8% | -0.9% | -14.6% | +20.0% | – | |
| – | +1.0% | -6.4% | +5.1% | +1.0% | -1.3% | +1.7% | +5.0% | +2.5% | +4.5% | -2.2% | +20.3% | – | |
| – | -36.7% | -12.4% | +19.8% | +1.1% | +19.0% | -11.0% | +21.5% | +3.1% | -8.3% | -34.0% | +19.5% | – | |
| – | +19.4% | -4.3% | +17.9% | -12.6% | +2.8% | +2.3% | +8.8% | +2.8% | +2.2% | +0.0% | +2.7% | – | |
| – | +81.2% | -32.2% | -0.8% | -1.8% | +16.2% | +3.9% | +4.4% | -11.6% | +78.5% | -33.5% | -1.8% | – | |
| – | +345.0% | -75.1% | +3.4% | -3.4% | +9.4% | +0.3% | +12.5% | -6.1% | +35.3% | -18.5% | +6.2% | – | |
| – | -70,717.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4,921.4% | -99.8% | +212.5% | -44.0% | +1,400.0% | -93.3% | +21.4% | +64.7% | +378.6% | -87.3% | +247.1% | – | |
| – | -2,216.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -153.4% | – | – | – | – | – | -1,385.8% | – | -923.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -282.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.